Recherche
-
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
(The Lancet HIV. vol. 5, n° 3, pp. e116-e125, 2018-03)Article de revue -
Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation
(Journal of the International AIDS Society. vol. 21, n° 1, 2018-01)Article de revue -
The Global Fund's Sixth Replenishment Conference: a challenge for France, a challenge for global health
(The Lancet. vol. 394, n° 10205, pp. 1214-1215, 2019-10-05)Article de revue -
High prevalence of Mycoplasma genitalium infection and macrolide resistance in patients enrolled in HIV pre-exposure prophylaxis program
(Medecine Et Maladies Infectieuses. vol. 49, n° 5, pp. 347-349, 2019-08)Article de revue -
The Global Fund in the era of SDGs: time to rethink?
(The Lancet Public Health. vol. 5, n° 1, pp. e17, 2020)Article de revueLibre accès -
Early ART Initiation Improves HIV Status Disclosure and Social Support in People Living with HIV, Linked to Care Within a Universal Test and Treat Program in Rural South Africa (ANRS 12249 TasP Trial)
(AIDS and Behavior, 2020-11-18)Article de revue -
No effect of test and treat on sexual behaviours at population level in rural South Africa
(AIDS. Official journal of the international AIDS Society. vol. 33, n° 4, pp. 709-722, 2019-03-15)Article de revue -
Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions
(Lancet. vol. 397, n° 10281, pp. 1316-1324, 2021-04-03)Article de revue -
Fitting a vaccine into the HIV prevention landscape
(Journal of the International AIDS Society. vol. 24, n° Suppl 7, pp. e25792, 2021-11)Article de revueLibre accès -
Gender differences in the use of cardiovascular interventions in HIV-positive persons
(Journal of the International AIDS Society. vol. 3, 2018-03)Article de revue